COVID-19 Vaccine: Mass Production by AstraZeneca begins, 100million doses to be produced by September.

New Delhi: As the cases of the novel coronavirus infection rise around the world with the UK being one of the most affected. A British Pharmaceutical company. Has announced that they will be undertaking mass production of the COVID-19 vaccine. Candidate from Oxford University.

AstraZeneca, the official partner for the COVID-19 vaccine. Candidate from Oxford, for the production and marketing of the vaccine, has begun to produce. AZD1222 jab, developed by Oxford University, in the UK, India, Switzerland, and Norway. The vaccine is under the human trial phase. But if successful, the company hopes to have millions of doses ready in the next few months. The company has reportedly signed a deal with UK. To produce 100 million doses. If the vaccine is successful in human trials. The company is expected to produce 2 billion doses worldwide, by mid-2021.

The widespread devastation by the virus also urged the company to carry out this program at no profit. According to reports in Express.co.uk.

Pascal Soriot, COVID-19 vaccine

Pascal Soriot Chief executive of AstraZeneca

Told BBC Radio 4’s Today program:” We are starting to manufacture this vaccine right know.”

And we have to have it ready to be used by the time we have the results.

” Of course, with this decision comes a risk but it is a financial risk. And all the financial risk is that if the vaccine doesn’t work.

” We will find this out at the end of August, then all the materials, all the vaccines we have manufactured will be wasted.”

” We felt that there are times in life that corporations need to set up and contribute to resolving a big problem like this one. So, we decided to do it at no profit.

In the initial phase of testing, the vaccines were tested on healthy volunteers of age 18-55. In the coming phases, researchers are to test the vaccine candidate in 10,260 more people. And they will also expand the age to include children and older people.

AstraZeneca, recently, announced a deal with the Serum Institute of India. To Produce the Oxford University’s vaccine candidate in India.

For more information click me .

Here are some more blogs:-

  1. Things you should not keep at home.
  2. Delhi Corona cases
  3. Ayush Kwath and Immunity booster
  4. Get certified with NPTEL courses

Total Page Visits: 177 - Today Page Visits: 1

Leave a Reply

Your email address will not be published. Required fields are marked *